LYFGENIA
STN: 125788
Proper Name: lovotibeglogene autotemcel (lovo-cel)
Tradename: LYFGENIA
Manufacturer: bluebird bio, Inc.
Indication:
- Treatment of patients 12 years of age or older with sickle cell disease and a history of vaso-occlusive events (VOEs).
Production Information
Supporting Documents
- December 8, 2023 Approval Letter - LYFGENIA
- December 8, 2023 Summary Basis for Regulatory Action - LYFGENIA
- Approval History, Letters, Reviews, and Related Documents - LYFGENIA